NASDAQ (USD): Regeneron Pharmaceuticals, Inc. (REGN)
Last Price
740.01
Today's Change
+15.14 (2.08%)
Day's Change
721.08 - 744.80
Trading Volume
930,382
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Stock Price
238
1000
110
900
600
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
Trump Transition Team Plans Sweeping Rollback of Biden's EV, Emissions Policies
2
Nasdaq Tops NYSE in Listings for Sixth Straight Year as IPO Optimism Grows
3
Goldman Sachs Economists See Fed Skipping a Rate Cut in January
4
Cocoa Soars to Fresh Record in Blow to World’s Chocolate Supply
5
US to Increase Tariffs on China’s Wafers, Polysilicon From 2025
#
Stock
Score
AAPL
Apple Inc.
TSLA
Tesla, Inc.
777
SOUN
SoundHound AI, Inc.
666
OKLO
Oklo Inc.
444
MSS
Maison Solutions Inc. Class A Common Stock
6
AGN
333
7
MSFT
Microsoft Corporation
8
PLTR
Palantir Technologies Inc.
244
9
ETE
222
10
ES
Eversource Energy
Last
Change
Volume
RIME
0.088
+0.007
1,119,293,881
TNXP
0.334
-0.196
957,251,140
GOEV
0.117
384,409,129
SLNA
0.03
-0.008
379,091,456
CYXT
0.065
0.00
369,807,727
NVDA
130.389
-1.61
245,969,955
UWT
0.164
-0.002
244,137,454
RGTI
11.13
+2.70
213,124,068
XTIA
0.045
+0.004
211,760,985
AGIL
0.197
+0.114
206,404,986
BRK-A
684,120.00
+332.18
1,494
BH-A
1,317.89
+117.89
1,502
RTLA
209.90
+74.87
0
ACSG
33.28
+33.28
99,050
EMSA
140.77
+30.77
EMLB
80.80
+30.30
NOVVU
41.00
+28.85
17,976
NOVV
37.00
+23.46
205,220
BH
256.69
+20.45
16,807
EDTX
63.24
+20.01
603,885
MELI
1,774.05
-343.25
2,940,447
MSTR
1,309.00
-138.99
2,237,917
MKL
1,395.13
-102.30
318,280
LOWC
30.18
-92.412
1,236,074
NOW
643.29
-87.83
5,025,012
762.00
-84.71
85,558,284
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
MCK
547.51
-70.00
4,067,959
NVR
8,468.49
-43.899
27,046
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....